Bozicevic, Field & Francis LLP
Methods of enhancing effectiveness of therapeutic viral immunogenic agent administration
Methods of reducing pre-existing humoral immunity to a viral immunogenic therapeutic agent such as adenovirus, using immunoapheresis are disclosed. Antibodies specific for the viral immunogenic therapeutic agent are selectively removed from the blood of an individual prior to administration of the viral immunogenic therapeutic agent by reaction extracorporeally with an immunosorbent which specifically binds the antibody. After the antibody is selectively removed from the blood, the blood is reinfused into the patient and the viral immunogenic therapeutic agent is administered. The invention also provides kits and compositions for selective removal of anti-viral antibody.
Cell Genesys, Inc.
A A A A A
A61P A61M A61K A61P A61M
inventional inventional inventional inventional additional
De Chao Yu Daniel R.
Yu Chen Henderson